Sacramento Business Journal

To call the past year a rollercoaster ride for Pam Marrone would be like calling a cyclone a zephyr.

Marrone turns 60 on Oct. 14, three days after her biotech company turns 10. The firm, Marrone Bio Innovations Inc., began life at a sprint, its revenues more than doubling year over year. Then, early this year, the Connecticut native found herself testifying before the Securities and Exchange Commission “for three agonizing days” about irregularities in the company’s revenue reporting — discoveries that led to the arrest of her former chief operating officer, Hector Absi, on charges of securities fraud. That case is ongoing. Marrone’s been absolved of any wrongdoing by the SEC.

Read the rest of the article here.